Cochrane Kidney and Transplant reviews

Our Reviews

Full list:

By subtopic:

ACUTE KIDNEY INJURY (25)
Anticoagulation (1)
Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
Antihypertensive agents (0)
Atrial natriuretic peptide (1)
Atrial natriuretic peptide for preventing and treating acute kidney injury
Contrast-induced nephropathy (0)
Diuretics (1)
Diuretics for preventing and treating acute kidney injury (protocol stage)
Dopamine and dopamine antagonists (1)
Fenoldopam for preventing and treating acute kidney injury (protocol stage)
Erythropoiesis-stimulating agents (1)
Erythropoiesis-stimulating agents for preventing acute kidney injury (protocol stage)
Growth factors (0)
Haemolytic uraemic syndrome (3)
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome
Interventions for atypical haemolytic uraemic syndrome
Hyperkalaemia (2)
Emergency interventions for hyperkalaemia
Pharmacological interventions for the acute management of hyperkalaemia in adults
Nutrition (1)
Nutritional support for acute kidney injury
Plasma volume expanders (0)
Post cardiac surgery (1)
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass
Kidney replacement therapy (9)
Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration
Intensity of continuous renal replacement therapy for acute kidney injury
Intermittent versus continuous renal replacement therapy for acute renal failure in adults
Continuous renal replacement therapy (CRRT) for rhabdomyolysis
Peritoneal dialysis for acute kidney injury
Biocompatible hemodialysis membranes for acute renal failure
Tidal versus other forms of peritoneal dialysis for acute kidney injury
Timing of kidney replacement therapy initiation for acute kidney injury
Bicarbonate versus lactate solutions for acute peritoneal dialysis
Prevention and Treatment (1)
Interventions for preventing and treating acute kidney injury in children (protocol stage)
Sodium bicarbonate supplements (1)
Sodium bicarbonate supplements for treating acute kidney injury
Statins (1)
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass
Thyroid hormones (1)
Thyroid hormones for acute kidney injury
CHRONIC KIDNEY DISEASE (90)
General management (53)
Acidosis control (1)
Correction of chronic metabolic acidosis for chronic kidney disease patients
Anaemia control (9)
Androgens for the anaemia of chronic kidney disease in adults
Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
Darbepoetin for the anaemia of chronic kidney disease
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Antihypertensive agents (4)
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
Blood pressure targets in people with cardiovascular disease
Calcium channel blockers for people with chronic kidney disease requiring dialysis
Bone and mineral disease (6)
Dietary interventions for mineral and bone disorder in people with chronic kidney disease
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
Interventions for metabolic bone disease in children with chronic kidney disease
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cardiovascular risk management (8)
Altered dietary salt intake for people with chronic kidney disease
Antiplatelet agents for chronic kidney disease
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
Pharmacological interventions for heart failure in people with chronic kidney disease
Interventions for improving adherence to dietary salt and fluid restrictions in people with chronic kidney disease (stage 4 and 5) (protocol stage)
Antioxidants for chronic kidney disease
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
Endocrine - other (3)
Interventions for treating sexual dysfunction in patients with chronic kidney disease
Metformin for preventing the progression of chronic kidney disease (protocol stage)
Growth hormone for children with chronic kidney disease
Lifestyle and complimentary therapies (7)
Alternate therapies (4)
Acupuncture and related interventions for symptoms of chronic kidney disease
Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
Exercise (2)
Exercise training for adults with chronic kidney disease
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
Psychosocial (1)
Interventions for treating sexual dysfunction in patients with chronic kidney disease
Nutrition (7)
Altered dietary salt intake for people with chronic kidney disease
Dietary interventions for adults with chronic kidney disease
Low protein diets for non-diabetic adults with chronic kidney disease
Protein restriction for children with chronic kidney disease
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (protocol stage)
The effect of a low salt diet on blood pressure and some hormones and lipids in people with normal and elevated blood pressure
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
Other (8)
Effect of decision-support tools on mobile phones on primary health care
eHealth interventions for people with chronic kidney disease
Interventions for improving health literacy in people with chronic kidney disease (protocol stage)
Interventions for improving sleep quality in people with chronic kidney disease
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
Oral adsorbents for preventing or delaying the progression of chronic kidney disease
Interventions for itch in people with advanced chronic kidney disease
Genetic disorders (3)
Anderson-Fabry disease (1)
Treatment for Anderson-Fabry disease
Cystinosis (0)
Polycystic kidney disease (2)
Transplantation versus other therapies for patients with polycystic liver disease (protocol stage)
Interventions for preventing the progression of autosomal dominant polycystic kidney disease
Glomerular diseases (32)
Diabetic kidney disease (14)
Alternate therapies (0)
Dietary interventions (4)
Altered dietary salt intake for preventing and treating diabetic kidney disease
Protein restriction for diabetic kidney disease (protocol stage)
Protein restriction for diabetic renal disease
Vitamin B and its derivatives for diabetic kidney disease
Education programmes (1)
Education programmes for people with diabetic kidney disease
Pharmacological interventions (9)
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Antihypertensive agents for preventing diabetic kidney disease
Glucose targets for preventing diabetic kidney disease and its progression
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Pentoxifylline for diabetic kidney disease
Prostaglandin E1 for preventing the progression of diabetic kidney disease
SGLT2 inhibitors for treating diabetes in people with chronic kidney disease (protocol stage)
Heparin and related substances for preventing diabetic kidney disease
Focal segmental glomerulosclerosis (1)
Interventions for focal segmental glomerulosclerosis in adults
HIV-associated nephropathy (1)
Interventions for HIV-associated nephropathy
Henoch-Schönlein Purpura (HSP) (1)
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)
IgA nephropathy (3)
Immunosuppressive agents for treating IgA nephropathy
Immunosuppressive therapy for IgA nephropathy in children (protocol stage)
Non-immunosuppressive treatment for IgA nephropathy
Lupus nephritis (1)
Immunosuppressive treatment for proliferative lupus nephritis
Membranoproliferative glomerulonephritis (0)
Membranous nephropathy (1)
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
Minimal change nephropathy (1)
Interventions for minimal change disease in adults with nephrotic syndrome
Nephrotic syndrome (8)
Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
Corticosteroid therapy for nephrotic syndrome in children
Human albumin infusion for treating oedema in people with nephrotic syndrome
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Lipid-lowering agents for nephrotic syndrome
Interventions for preventing infection in nephrotic syndrome
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
Rapidly progressive glomerulonephritis (1)
Interventions for renal vasculitis in adults
Investigations, procedures and process of care (1)
Kidney biopsies (0)
Referral strategies (1)
Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
Prognosis reviews (1)
Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease (protocol stage)
DIAGNOSTIC TEST ACCURACY REVIEWS (5)
Acute pyelonephritis (1)
Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children
cytomegalovirus (CMV) diagnostic tests (0)
Iron measurements (0)
Other (1)
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people
Renal scarring (0)
Suprapubic urine aspiration (0)
Transplantation (2)
Cardiac testing for coronary artery disease in potential kidney transplant recipients
Measurement of serum galactomannan to detect invasive aspergillosis in immunocompromised patients
Vesicoureteric reflux (1)
Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections
Ureteric colic (0)
DRUGS AND THE KIDNEY (7)
Early and late adverse effects on the kidney after treatment for childhood cancer
Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
Loop diuretics for patients receiving blood transfusions
Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function
Teicoplanin versus vancomycin for proven or suspected infection
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
DRUGS: OTHER (1)
Loop diuretics for patients receiving blood transfusions
ELECTROLYTE DISORDERS (2)
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
Interventions for chronic non-hypovolaemic hypotonic hyponatraemia
KIDNEY FAILURE / END-STAGE KIDNEY DISEASE (71)
General management (31)
Biochemical control (0)
Acidosis (0)
Potassium (0)
Anaemia control (3)
Early versus delayed erythropoietin for the anaemia of end-stage kidney disease
Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients
Interventions for erythropoietin-resistant anaemia in dialysis patients
Antihypertensive agents (0)
Bone and mineral disease (1)
Vitamin D compounds for people with chronic kidney disease requiring dialysis
Cardiovascular risk management (3)
Aldosterone antagonists (1)
Aldosterone antagonists for people with chronic kidney disease requiring dialysis
Cholesterol (1)
HMG CoA reductase inhibitors (statins) for dialysis patients
Homocysteine (1)
Interventions for lowering plasma homocysteine levels in dialysis patients
Endocrine - other (0)
Anabolic steroids (0)
Sex hormones (0)
Infection (5)
Dressings for the prevention of surgical site infection
Hepatitis B vaccines achieve antibody production in patients with chronic renal failure, but we do not know if the vaccines are protective
How often should dressings on central venous access devices (CVADs) be changed to reduce catheter-related infection?
Interventions for dialysis patients with hepatitis C virus (HCV) infection
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units
Lifestyle and complimentary therapies (3)
Alternate therapies (0)
Exercise (1)
Exercise training for adults undergoing maintenance dialysis
Other (0)
Psychosocial (2)
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis
Psychosocial interventions for preventing and treating depression in dialysis patients
Nutrition (3)
Carnitine supplements for people with chronic kidney disease requiring dialysis (protocol stage)
Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis
The effect of a low salt diet on blood pressure and some hormones and lipids in people with normal and elevated blood pressure
Other (6)
Cramps (0)
Dry mouth (2)
Interventions for the management of dry mouth: topical therapies
Non-drug treatments for dry mouth symptoms
Fatigue (1)
Interventions for fatigue in people with chronic kidney disease requiring dialysis (protocol stage)
Pruritus (itching) (1)
Interventions for itch in people with advanced chronic kidney disease
Restless legs (2)
Interventions for chronic kidney disease-associated restless legs syndrome
Opiods for restless legs syndrome
Treatment options (7)
Conservative management (1)
Dialysis versus conservative management for stage 5 chronic kidney disease in the elderly (protocol stage)
Dialysis (4)
Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults
Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease
Peritoneal dialysis versus haemodialysis for people commencing dialysis (protocol stage)
Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease
Palliative care (1)
Advance care planning for haemodialysis patients
Transplantation (1)
Pre-emptive versus non pre-emptive kidney transplantation for end-stage kidney disease (protocol stage)
Haemodialysis (30)
Access (8)
Catheters (2)
Does heparin locking prevent blocking of central venous catheters in adults when compared to locking with normal saline?
Interventions for treating central venous haemodialysis catheter malfunction
Contrast agents (0)
Fluid control (0)
Needling devices (0)
Vascular access (6)
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
Medicines to prevent blockage of vascular access following surgery for formation of arteriovenous fistula or graft
Pre-emptive correction for haemodialysis arteriovenous access stenosis
Preoperative vascular access evaluation for haemodialysis patients
Ultrasound use for the placement of haemodialysis catheters
Anticoagulation (3)
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Anticoagulation for people receiving long-term haemodialysis (protocol stage)
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
Dialysate (2)
Low dialysate sodium levels for chronic haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis
Dialysers (2)
Dialyser reuse (0)
Dual dialysers (0)
Membranes (2)
High-flux versus low-flux membranes for end-stage kidney disease
Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease
Ultrafiltration control (0)
Haemodialysis delivery (3)
Dose / duration (1)
Less intensive versus conventional haemodialysis for people with end-stage kidney disease (protocol stage)
Kt/V and creatinine clearance targets (0)
Treatment options (2)
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
Home versus in-centre haemodialysis for end-stage kidney disease
Infection - prevention and treatment (7)
Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis
Central venous catheter coating with antiseptics or antibiotics for reducing catheter-related infections in adults
Dressings for the prevention of surgical site infection
Interventions for preventing infectious complications in haemodialysis patients with central venous catheters
Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis
Skin antisepsis for reducing central venous catheter-related infections
Surgical hand antisepsis to reduce surgical site infection
Other (3)
Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access
Human albumin for intradialytic hypotension in haemodialysis patients
Interventions for preventing haemodialysis dysequilibrium syndrome (protocol stage)
Thrombosis / patency (2)
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (protocol stage)
Medicines to prevent blockage of vascular access following surgery for formation of arteriovenous fistula or graft
Peritoneal dialysis (10)
Biochemical control (0)
Catheters (3)
Catheter configuration (0)
Catheter placement (2)
Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients (protocol stage)
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients
Transfer systems (1)
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease
Dialysate (1)
Exchange volumes (0)
Solutions (1)
Biocompatible dialysis fluids for peritoneal dialysis
Infection - prevention and treatment (4)
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients
Surgical hand antisepsis to reduce surgical site infection
Treatment for peritoneal dialysis-associated peritonitis
Other (1)
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
Peritoneal dialysis delivery (1)
Clearance targets (0)
Dose / duration (0)
Treatment options (1)
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease
PROCESS OF CARE (8)
END-OF-LIFE CARE (2)
End-of-life care pathways for the dying
Home-based end-of-life care
END-STAGE KIDNEY DISEASE (0)
Blood pressure control in haemodialysis patients (0)
OTHER (5)
Discharge planning from hospital
Follow-up services to improve the long-term after-effects of a stay in the intensive care unit
Improving outcomes for people with multiple chronic conditions
Interventions to improve people's drug-taking behaviour with lipid-lowering drugs
Shared care across the interface between primary and specialty care in chronic disease management
SCREENING TESTS (1)
Screening with urinary dipsticks for reducing morbidity and mortality
TRANSPLANTATION (0)
Medication compliance (0)
URINARY TRACT INFECTION (0)
Telephone versus in-office management (0)
TRANSPLANTATION: KIDNEY (45)
Acute rejection (3)
Antibody therapy (3)
Belatacept for kidney transplant recipients
Interventions for treating antibody-mediated acute rejection in kidney transplant recipients (protocol stage)
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients
Complications and co-interventions (14)
Antihypertensive treatment (1)
Antihypertensive treatment for kidney transplant recipients
Bone and mineral disease (1)
Interventions for preventing bone disease in kidney transplant recipients
Cardiovascular risk (3)
Fish oil for kidney transplant recipients
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
Interventions for lowering plasma homocysteine levels in kidney transplant recipients
Diabetes (0)
Infection (7)
Prevention (5)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Treatment (2)
Antibiotics for asymptomatic bacteriuria in kidney transplant recipients
Interventions for BK virus infection in kidney transplant recipients (protocol stage)
Nutrition (1)
Fish oil for kidney transplant recipients
Other (1)
(a traditional Chinese medicine) for kidney transplant recipients
Diagnosis and screening (1)
Serum and urine nucleic acid screening tests for polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients (protocol stage)
Induction therapy / primary immunosuppression (7)
Antibody therapy (3)
Belatacept for kidney transplant recipients
Interleukin 2 receptor antagonists for kidney transplant recipients
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
Antiproliferative agents (1)
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
Calcineurin inhibitors (2)
Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients (protocol stage)
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients
Target of rapamycin inhibitors (mTOR-I) (1)
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
Lifestyle and complimentary therapies (1)
Exercise (1)
Exercise training for adult kidney transplant recipients (protocol stage)
Maintenance immunosuppression (2)
Antiproliferative agents (0)
Calcineurin inhibitors (1)
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
Steroids (1)
Steroid avoidance or withdrawal for kidney transplant recipients
Organ donation (1)
Interventions for increasing solid organ donor registration
Other (2)
(a traditional Chinese medicine) for kidney transplant recipients
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation (protocol stage)
Transplantation procedures (14)
Procedural (7)
Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients
Cardiac testing for coronary artery disease in potential kidney transplant recipients
Dressings for the prevention of surgical site infection
Early versus late removal of urinary catheter after kidney transplantation (protocol stage)
Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury
Surgical hand antisepsis to reduce surgical site infection
Interventions for preventing thrombosis in solid organ transplant recipients
Surgical (7)
Donors (3)
Laparoscopic versus open nephrectomy for live kidney donors
Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation
Recipients (4)
Early versus late ureteric stent removal after kidney transplantation
Minimally invasive surgical techniques for kidney transplantation (protocol stage)
Normal saline versus lower-chloride solutions for kidney transplantation
Routine intraoperative ureteric stenting for kidney transplant recipients
TRANSPLANTATION: KIDNEY-PANCREAS (11)
Acute rejection (0)
Complications and co-interventions (5)
Cardiovascular risk (0)
Diabetes (0)
Infection (5)
Prevention (5)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Treatment (0)
Nutrition (0)
Diagnosis and screening (1)
Serum and urine nucleic acid screening tests for polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients (protocol stage)
Induction therapy / primary immunosuppression (0)
Antibody therapy (0)
Antiproliferative agents (0)
Calcineurin inhibitors (0)
Target of rapamycin inhibitors (mTOR-I) (0)
Maintenance immunosuppression (1)
Calcineurin inhibitors (0)
Steroids (1)
Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
Organ donation (1)
Interventions for increasing solid organ donor registration
Other (1)
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation (protocol stage)
Transplantation procedures (2)
Procedures (2)
Dressings for the prevention of surgical site infection
Surgical hand antisepsis to reduce surgical site infection
Surgery (0)
Donors (0)
Recipients (0)
TRANSPLANTATION: LUNG (1)
Acute rejection (0)
Chronic lung allograft dysfunction (CLAD) (0)
Lifestyle and complimentary therapies (1)
Exercise training for adult lung transplant recipients
TRANSPLANTATION: SOLID ORGAN (21)
Acute rejection (0)
Complications and co-interventions (7)
Cardiovascular risk (0)
Diabetes (0)
Infection (6)
Prevention (6)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Treatment (0)
Malignancy (1)
Interventions for preventing of non-melanoma skin cancers in high-risk groups
Nutrition (0)
Induction therapy / primary immunosuppression (4)
Antibody induction therapy for lung transplant recipients
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients
Medical interventions to prevent early graft rejection after liver transplantation
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
Maintenance immunosuppression (2)
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients
Medical interventions to prevent graft rejection after liver transplantation
Organ donation (1)
Interventions for increasing solid organ donor registration
Other (3)
Exercise-based cardiac rehabilitation for patients following a heart transplantation
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients
Synbiotics, prebiotics and probiotics for solid organ transplant recipients
Prognosis reviews (1)
Predictive factors for BK polyomavirus infection in solid organ transplant recipients (protocol stage)
Transplantation procedures (3)
Procedures (2)
Dressings for the prevention of surgical site infection
Surgical hand antisepsis to reduce surgical site infection
Surgical (1)
Donor (0)
Recipients (1)
Interventions for preventing thrombosis in solid organ transplant recipients
URINARY TRACT INFECTION (28)
Diagnosis (1)
Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children
Prevention and prophylaxis (10)
Cranberries for preventing urinary tract infections
D-mannose for preventing and treating urinary tract infections
Interventions for preventing recurrent urinary tract infections during pregnancy
Long-term antibiotics for preventing recurrent urinary tract infection in children
Methenamine hippurate for preventing urinary tract infections
Newborn circumcision for the prevention of urinary tract infections in infancy
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women
Oestrogens for preventing recurrent urinary tract infection in postmenopausal women
Probiotics for preventing urinary tract infections in adults and children
Probiotics for preventing urinary tract infection in people with neuropathic bladder
Treatment (17)
Asymptomatic urinary tract infection (3)
Antibiotics for asymptomatic bacteriuria
Interventions for covert bacteriuria in children
D-mannose for preventing and treating urinary tract infections
Lower urinary tract infection (12)
Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women
Antibiotics for treating lower urinary tract infection in children
Antimicrobial agents for treating uncomplicated urinary tract infection in women
Chinese herbal medicine for treating recurrent urinary tract infections in women
D-mannose for preventing and treating urinary tract infections
Duration of antibacterial treatment for uncomplicated urinary tract infection in women
Modes of administration of antibiotics for symptomatic severe urinary tract infections
Non-steroidal anti-inflammatory drugs for treating symptomatic uncomplicated urinary tract infections in non-pregnant adult women (protocol stage)
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children
Cranberries for treating urinary tract infections
Quinolones for uncomplicated acute cystitis in women
Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women
Pyelonephritis (2)
Antibiotics for acute pyelonephritis in adults (protocol stage)
Antibiotics for acute pyelonephritis in children
Urine collection (0)
Urological and surgical procedures (0)
UROLOGY (1)
VESICOURETERIC REFLUX (1)
Treatment (1)
Interventions for primary vesicoureteric reflux